Understanding how brain cells contribute to a severe childhood brain disease
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
This study is looking at how certain brain cells called microglia might make things worse for kids with Globoid Cell Leukodystrophy (GLD), a serious disease that affects young children, to help find better treatments.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-10870084 on NIH RePORTER |
What this research studies
This research investigates the role of microglia, a type of brain cell, in Globoid Cell Leukodystrophy (GLD), a devastating disease that affects children under five years old. The study aims to understand how these cells may activate immune responses that worsen the disease, which is characterized by rapid cognitive and behavioral decline. By examining the interactions between microglia and CD8+ T cells, the research seeks to uncover new mechanisms that could lead to better treatments for GLD. The findings could provide insights into the cellular changes that occur in the brain during this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with Globoid Cell Leukodystrophy, particularly those under the age of five.
Not a fit: Patients with other neurological disorders or those outside the age range of 0-5 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve outcomes for children suffering from Globoid Cell Leukodystrophy.
How similar studies have performed: While the specific role of microglia in GLD is being explored for the first time, similar research in other neurological conditions has shown promise in understanding immune cell interactions in brain diseases.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Sutter, Pearl a — University of Connecticut Sch of Med/dnt
- Study coordinator: Sutter, Pearl a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.